Diadema Partners »

Reviva Pharmaceutcls Hldgs I shares owned by Diadema Partners

Quarter-by-quarter ownership of Reviva Pharmaceutcls Hldgs I (RVPH) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Reviva Pharmaceutcls Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Reviva Pharmaceutcls Hldgs I held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviva Pharmaceutcls Hldgs I by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $924k 2.5M 0.37

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Reviva Pharmaceutcls Hldgs I

Vanguard Group
Diadema Partners
Millennium Management
Persistent Asset Partners
Susquehanna International
Geode Capital Management
Citadel Advisors
UBS Group
Jane Street
Renaissance Technologies
Simplex Trading
EMC Capital Management
State Street Corporation
XTX Topco
Lido Advisors

View all funds holding Reviva Pharmaceutcls Hldgs I